Cargando…
Journal Club Review of “Avacopan for the Treatment of ANCA‐Associated Vasculitis”
JOURNAL CLUB: Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the treatment of ANCA‐associated vasculitis. N Engl J Med 2021;384:599‐609. OBJECTIVE: The C5a receptor inhibitor avacopan is being studied for the treatment of antineutrophil cytoplasmic antibody (ANCA)‐asso...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274376/ https://www.ncbi.nlm.nih.gov/pubmed/35167187 http://dx.doi.org/10.1002/acr2.11412 |